Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Obesity Medicine Association

Obesity Medicine Association

Medical Professional Organization

Appears in 1 story

Stories

The battle to put GLP-1 drugs on Medicare

Rule Changes

Endorsed BALANCE model and advocates for barrier-free access

Medicare has been banned from covering weight loss drugs since 2003. CMS launched BALANCE in December 2025, a voluntary model offering $50-per-month Ozempic and Wegovy access for 10% of Medicare enrollees starting July 2026.

Updated 1 hour ago